StemCell Institute Inc. (7096.T)
JPY 1315.0
(2.02%)
JPY 1315.0
(2.02%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.83 Billion JPY | 14.51% |
| 2022 | -3.31 Billion JPY | 5.5% |
| 2021 | -3.51 Billion JPY | -27.99% |
| 2020 | -2.74 Billion JPY | 9.28% |
| 2019 | -3.02 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -3.03 Billion JPY | -6.81% |
| 2023 Q4 | -2.83 Billion JPY | -5.4% |
| 2023 Q3 | -2.69 Billion JPY | 17.41% |
| 2023 Q2 | -3.25 Billion JPY | 0.53% |
| 2023 Q1 | -3.27 Billion JPY | 1.27% |
| 2023 FY | -2.83 Billion JPY | 14.51% |
| 2022 Q3 | -3.3 Billion JPY | 4.11% |
| 2022 Q2 | -3.44 Billion JPY | 0.0% |
| 2022 Q4 | -3.31 Billion JPY | -0.3% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 481.921% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | -150.167% |
| GNI Group Ltd. | -17.93 Billion JPY | 84.182% |
| Linical Co., Ltd. | -4.46 Billion JPY | 36.442% |
| Trans Genic Inc. | -221.16 Million JPY | -1182.619% |
| MEDINET Co., Ltd. | -4.39 Billion JPY | 35.441% |
| Soiken Holdings Inc. | -4.79 Billion JPY | 40.778% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 297.885% |
| AnGes, Inc. | -3.79 Billion JPY | 25.304% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -574.123% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 111.389% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | -469.454% |
| NanoCarrier Co., Ltd. | -466.34 Million JPY | -508.293% |
| Carna Biosciences, Inc. | -2.7 Billion JPY | -4.827% |
| CanBas Co., Ltd. | -1.88 Billion JPY | -50.236% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | -188.834% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | 16.493% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | -174.201% |
| Kidswell Bio Corporation | 343.58 Million JPY | 925.625% |
| PeptiDream Inc. | 3.29 Billion JPY | 186.171% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | -191.669% |
| Ribomic Inc. | -2.09 Billion JPY | -35.1% |
| SanBio Company Limited | -3.78 Billion JPY | 25.146% |
| Healios K.K. | -2.19 Billion JPY | -29.532% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | -200.23% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -2.62 Billion JPY | -8.102% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | -100.186% |
| StemRIM | -8.41 Billion JPY | 66.269% |
| CellSource Co., Ltd. | -4.68 Billion JPY | 39.431% |
| FunPep Company Limited | -1.79 Billion JPY | -58.179% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | -32.776% |
| Stella Pharma Corporation | -1.11 Billion JPY | -153.417% |
| TMS Co., Ltd. | -3.44 Billion JPY | 17.695% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | 48.94% |
| Cuorips Inc. | -5.56 Billion JPY | 48.988% |
| K Pharma,Inc. | -3.26 Billion JPY | 13.154% |
| Takara Bio Inc. | -32.2 Billion JPY | 91.191% |
| ReproCELL Incorporated | -2.93 Billion JPY | 3.481% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | -329.187% |
| Japan Tissue Engineering Co., Ltd. | -2.06 Billion JPY | -37.284% |
| CellSeed Inc. | -2.01 Billion JPY | -40.989% |